Merit Medical Systems Inc (MMSI)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Key Insights
Critical company metrics and information
Share Price
$102.64Market Cap
$5.98 BillionTotal Outstanding Shares
58.28 Million SharesTotal Employees
6,950Dividend
No dividendIPO Date
February 26, 1992SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.merit.com
Historical Stock Splits
If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution Date | Split Amount |
---|---|
May 6, 2011 | 5-for-4 |
December 3, 2003 | 4-for-3 |
August 15, 2003 | 4-for-3 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $214.31 Million |
Net Cash Flow From Investing Activities | $-162.55 Million |
Net Cash Flow From Financing Activities | $410.37 Million |
Net Cash Flow From Operating Activities | $214.31 Million |
Net Cash Flow, Continuing | $462.13 Million |
Net Cash Flow From Investing Activities, Continuing | $-162.55 Million |
Net Cash Flow | $462.13 Million |
Net Cash Flow From Financing Activities, Continuing | $410.37 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Income Tax Expense/Benefit | $28.28 Million |
Cost Of Revenue | $704.99 Million |
Benefits Costs and Expenses | $1.18 Billion |
Net Income/Loss | $120.04 Million |
Provision For Loan, Lease, And Other Losses | $1.27 Million |
Operating Expenses | $468.14 Million |
Operating Income/Loss | $152.74 Million |
Costs And Expenses | $1.18 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Gross Profit | $620.88 Million |
Revenues | $1.33 Billion |
Nonoperating Income/Loss | $-4.43 Million |
Diluted Earnings Per Share | $2.05 |
Other Operating Expenses | $83.73 Million |
Basic Average Shares | $116.35 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income/Loss From Continuing Operations After Tax | $120.04 Million |
Net Income/Loss Attributable To Parent | $120.04 Million |
Selling, General, and Administrative Expenses | $384.41 Million |
Income/Loss From Continuing Operations Before Tax | $148.31 Million |
Basic Earnings Per Share | $2.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Net Income/Loss Available To Common Stockholders, Basic | $120.04 Million |
Diluted Average Shares | $118.20 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Equity Attributable To Noncontrolling Interest | $0.00 |
Noncurrent Assets | $1.30 Billion |
Other Non-current Assets | $910.11 Million |
Inventory | $310.53 Million |
Current Liabilities | $201.08 Million |
Equity | $1.32 Billion |
Noncurrent Liabilities | $853.60 Million |
Other Current Assets | $767.79 Million |
Current Assets | $1.08 Billion |
Long-term Debt | $750.50 Million |
Assets | $2.38 Billion |
Other Non-current Liabilities | $103.09 Million |
Fixed Assets | $389.65 Million |
Equity Attributable To Parent | $1.32 Billion |
Liabilities And Equity | $2.38 Billion |
Liabilities | $1.05 Billion |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.